ARQT

NASDAQ · Biotechnology

Arcutis Biotherapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$26.27

-0.39 (-1.46%)

As of Jun 23, 9:58 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +226.5% upside

Low Target $74.20

Average Target $85.78

High Target $112.10

Current Price $26.27

Current
$26.27

Target
$85.78

$74.20 $85.78 avg $112.10

Scenario Analysis

Bear Case

$74.20

182.5%

Low target

Base Case

$85.78

+226.5%

Avg target

Bull Case

$112.10

+326.7%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$31.77

-17.3% from high

52-Week Low

$13.06

+101.1% from low

50-Day SMA

$27.64

-5.0% vs SMA

200-Day SMA

$20.38

+28.9% vs SMA

RSI (14)

67.5

Neutral

Target vs 52W High

$85.78

+170.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%